Pharmaceutical

Tempus AI expands oncology collaboration with Takeda

Tempus AI has announced an expanded collaboration with Takeda to enhance oncology research and development.

Sep 28, 2024 - 04:00
Tempus AI expands oncology collaboration with Takeda
Tempus AI has announced an expanded collaboration with Takeda to enhance oncology research and development.
Read the original article

Tags:

Previous Article

API Chemical Contract Manufacturing Companies for the Pharmaceutical Industry

Next Article

Phare Bio receives ARPA-H funds for AI drug discovery platform

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Watch: What is in utero gene editing?

Watch: What is in utero gene editing?

Feb 21, 2024

STAT+: Bayer’s promising menopause drug trial results highlight growing interest in long-neglected condition

STAT+: Bayer’s promising menopause drug trial results h...

Jan 10, 2024

Opinion: What Rosalynn Carter understood about mental health

Opinion: What Rosalynn Carter understood about mental h...

Nov 21, 2023